Plasma exosomal RNAs has potential as both clinical biomarkers and therapeutic targets of dermatomyositis.
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keab753
Abstract: OBJECTIVES Dermatomyositis (DM) is characterized by skeletal muscle weakness and cutaneous manifestations. Plasma exosomes (EXOs) contain proteins, RNAs, DNA, and lipid cargoes and are transferred among cells. Deeply investigated plasma EXO RNAs potentially improve our… read more here.
Keywords: hsa mir; plasma exos; therapeutic targets; biomarkers therapeutic ... See more keywords